Inflammation, Repair and Development Section, National Heart and Lung Institute, Imperial College London, London, UK.
Respiratory Pharmacology, Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
Thorax. 2018 Jun;73(6):546-556. doi: 10.1136/thoraxjnl-2017-210010. Epub 2017 Oct 27.
Alveolar macrophages are sentinels of the airways that must exhibit immune restraint to innocuous antigens but elicit a robust inflammatory response to pathogenic threats. How distinction between these dichotomous functions is controlled is poorly defined.Neutrophils are the first responders to infection, and we hypothesised that they may free alveolar macrophages from their hyporesponsive state, promoting their activation. Activation of the inflammasome and interleukin (IL)-1β release is a key early inflammatory event that must be tightly regulated. Thus, the role of neutrophils in defining inflammasome activation in the alveolar macrophage was assessed.
Mice were infected with the X31 strain of influenza virus and the role of neutrophils in alveolar macrophage activation established through administration of a neutrophil-depleting (1A8) antibody.
Influenza elicited a robust IL-1β release that correlated (r=0.6849; p<0.001) with neutrophil infiltrate and was ablated by neutrophil depletion. Alveolar macrophages were shown to be the prominent source of IL-1β during influenza infection, and virus triggered the expression of Nod-like receptor protein 3 (NLRP3) inflammasome and pro-IL-1β in these cells. However, subsequent activation of the inflammasome complex and release of mature IL-1β from alveolar macrophages were critically dependent on the provision of a secondary signal, in the form of antimicrobial peptide mCRAMP, from infiltrating neutrophils.
Neutrophils are critical for the activation of the NLRP3 inflammasome in alveolar macrophages during respiratory viral infection. Accordingly, we rationalise that neutrophils are recruited to the lung to confront a viable pathogenic threat and subsequently commit alveolar macrophages to a pro-inflammatory phenotype to combat infection.
肺泡巨噬细胞是气道的哨兵,必须对无害抗原表现出免疫抑制,但对致病威胁产生强烈的炎症反应。如何控制这种二分功能之间的区别尚未明确。中性粒细胞是感染的第一反应者,我们假设它们可以使肺泡巨噬细胞摆脱低反应状态,促进其激活。炎性小体的激活和白细胞介素 (IL)-1β 的释放是一个关键的早期炎症事件,必须进行严格的调节。因此,评估了中性粒细胞在定义肺泡巨噬细胞中炎性小体激活中的作用。
用 X31 流感病毒株感染小鼠,并通过给予中性粒细胞耗竭 (1A8) 抗体来确定中性粒细胞在肺泡巨噬细胞激活中的作用。
流感引起了强烈的 IL-1β 释放,与中性粒细胞浸润呈正相关 (r=0.6849;p<0.001),并被中性粒细胞耗竭所消除。研究表明,在流感感染期间,肺泡巨噬细胞是 IL-1β 的主要来源,病毒触发了这些细胞中 Nod 样受体蛋白 3 (NLRP3) 炎性小体和 pro-IL-1β 的表达。然而,随后肺泡巨噬细胞中炎性小体复合物的激活和成熟的 IL-1β 的释放严重依赖于来自浸润中性粒细胞的二次信号,以抗菌肽 mCRAMP 的形式提供。
中性粒细胞在呼吸道病毒感染期间肺泡巨噬细胞中 NLRP3 炎性小体的激活中至关重要。因此,我们推断中性粒细胞被招募到肺部以应对可行的致病威胁,随后使肺泡巨噬细胞向促炎表型转变以抵抗感染。